<DOC>
	<DOCNO>NCT00049972</DOCNO>
	<brief_summary>A study obtain safety tolerability data</brief_summary>
	<brief_title>Major Depressive Disorder Study In Adults</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Patient must primary diagnosis Major Depressive Disorder ( MDD ) . Discontinued selective serotonin reuptake inhibitor ( SSRI ) serotoninnorepinephrine reuptake inhibitor ( SNRI ) regimen due intolerability . Minimum time frame last dose previous antidepressant initiation study drug one week . Maximum time frame last dose prior antidepressant initiation study drug 2 month . Patient previously treat study drug . Is experience adverse event attribute previous SSRI/SNRI use resolve least one week prior Baseline Visit . Has history seizure disorder . Has meet criterion substance abuse dependence within 6 month prior Baseline Visit . Currently use antidepressant . Currently pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Major Depressive Disorder Open-label discontinue</keyword>
</DOC>